Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle
Endpoints
Thu, 06/3/21 - 10:51 am
Novartis
ASCO 2021
CAR-T
Kymriah
follicular lymphoma
Gilead Sciences
Yescarta
Dr. Carl June's drugmaker scraps lead CAR-T program after 2 trial participants die
Beckers Hospital Review
Thu, 06/3/21 - 10:44 am
Tmunity
CAR-T
patient deaths
FDA sets November review date for J&J’s multiple myeloma CAR-T cilta-cel
Pharmaforum
Thu, 05/27/21 - 11:59 pm
JNJ
FDA
Multiple Myeloma
CAR-T
cilta-cel
Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Endpoints
Wed, 05/26/21 - 11:01 am
R&D
solid tumors
CAR-T
Off-the-shelf CAR-T, a Tagrisso rival and the next breast cancer drugs: a look ahead at ASCO
BioPharma Dive
Thu, 05/20/21 - 11:18 pm
ASCO 2021
Allogene
CAR-T
Bristol Myers Squibb
EQRx
Allogene sets out to prove that their off-the-shelf approach to CAR-T can beat the personalized approach
Endpoints
Wed, 05/19/21 - 11:11 pm
ASCO 2021
Allogen
blood cancer
CAR-T
Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science
Endpoints
Thu, 05/13/21 - 11:59 pm
Sanofi
Cellectis
allogeneic cells
CAR-T
alemtuzumab
Lemtrada
Bristol Myers sees automation, virtual reality on the horizon for pair of new CAR-T manufacturing plants
Fierce Pharma
Mon, 05/3/21 - 11:11 am
Bristol Myers Squibb
CAR-T
drug manufacturing
Breyanzi
Abecma
Bristol Myers, flush with pair of CAR-T approvals, blueprints first cell therapy factory in Europe
Fierce Pharma
Thu, 04/22/21 - 11:14 am
Bristol-Myers Squibb
The Netherlands
CAR-T
cell therapy
drug manufacturing
Vertex adds a new gene editing partner, paying Obsidian $75M for controllable CRISPR system
Endpoints
Thu, 04/22/21 - 10:54 am
Vertex Pharmaceuticals
gene editing
CAR-T
Obsidian
Anixa Hits FDA Speedbump for Ovarian Cancer CAR-T Trial Approval
BioSpace
Tue, 04/20/21 - 10:56 am
Anixa Biosciences
FDA
CAR-T
ovarian cancer
AACR attendees told about tactics to tackle loss of T cell function in CAR T cell treatment
Biopharma Reporter
Mon, 04/19/21 - 11:10 am
Memorial Sloan Kettering
AACR
CAR-T
Precision reacquires rights to allogeneic CAR-Ts from Servier
Fierce Biotech
Fri, 04/16/21 - 09:58 am
Precision Biosciences
allogeneic cells
CAR-T
Servier
Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors
Fierce Biotech
Wed, 04/14/21 - 09:30 am
Bluebird Bio
PsiOxus
CAR-T
solid tumors
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
Mon, 04/12/21 - 11:34 pm
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
Sanofi spends $160M in bet that Tidal’s tech gets it to off-the-shelf CAR-T therapy
MedCity News
Sun, 04/11/21 - 11:26 pm
Sanofi
M&A
Tidal Therapeutics
CAR-T
MRNA
Kite: New data offers transparency into CAR T cell therapy manufacturing in real world setting
Biopharma Reporter
Wed, 04/7/21 - 07:13 pm
Kite Pharma
Yescarta
CAR-T
New CAR-T therapy from Bristol, Bluebird effective but too costly, ICER finds
BioPharma Dive
Tue, 04/6/21 - 11:00 pm
Bristol Myers Squibb
Bluebird Bio
ICER
Multiple Myeloma
CAR-T
Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an advantage: analysts
Fierce Pharma
Mon, 03/29/21 - 10:55 pm
Bristol Myers Squibb
Bluebird Bio
CAR-T
JNJ
Legend Biotech
Abecma
FDA approves first CAR-T cell therapy for multiple myeloma
BioPharma Dive
Mon, 03/29/21 - 10:56 pm
Bristol-Myers Squibb
Bluebird Bio
CAR-T
Multiple Myeloma
Abecma
FDA
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »